Mouse Anti-FCMR scFv-Fc Chimera (VS-0325-FY120) (CAT#: VS-0325-FY120)
The anti-FCMR scFv-Fc antibody targets FCMR (CD32B), an Fcγ receptor involved in immune regulation and B-cell signaling. It is useful for studying the role of FCMR in immune tolerance, autoimmunity, and B-cell biology.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Immunofluorescent staining of human cell line U-251 MG shows localization to cytosol & focal adhesion sites.)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/if_selected.jpg

(Endothelial cells Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_B_8_5.jpg

(Glandular cells Staining: High Intensity: Strong Quantity:>75% Location: Cytoplasmic/ membranous Peripheral nerve/ganglion Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_A_8_3.jpg

(Cholangiocytes Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_A_8_4.jpg

(Cells in glomeruli Staining: Medium Intensity: Moderate Quantity: 75%-25% Location: Cytoplasmic/ membranous Cells in tubules Staining: High Intensity: Strong Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_A_7_5.jpg

(Cells in seminiferous ducts Staining: High Intensity: Strong Quantity:>75% Location: Cytoplasmic/ membranous Leydig cells Staining: High Intensity: Strong Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_A_6_6.jpg

(Non-germinal center cells Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_A_8_8.jpg

(Germinal center cells Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous Non-germinal center cells Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous Squamous epithelial cells Staining: Medium Intensity: Moderate Quantity:>75% Location: Cytoplasmic/ membranous)
* Image credit: Human Protein Atlas v21.proteinatlas.org/images/3910/11162_A_4_8.jpg

(Cell lines ordered by descending RNA expression order)
* Image credit: Human Protein Atlas v21.proteinatlas.org/ENSG00000162894-FCMR
Specifications
- Immunogen
- Human FcμR protein.
- Host Species
- Mouse
- Type
- Mouse IgG1, scFv-Fc
- Specificity
- Human FCMR
- Species Reactivity
- Human
- Clone
- HM7
- Applications
- Western Blot, Inhibition, Flow Cytometry
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Concentration
- Please refer to the vial label for the specific concentration.
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
- Shipping
- Ice packs
Applications
- Application Notes
- Flow Cytometry: 10 μg/mL
Target
- Alternative Names
- Fc Fragment Of IgM Receptor; Regulator Of Fas-Induced Apoptosis Toso; Fas Apoptotic Inhibitory Molecule 3; IgM Fc Fragment Receptor; FAIM3; TOSO; Immunoglobulin Mu Fc Receptor; IgM Fc Receptor; Fc Mu Receptor
- Gene ID
- 9214
- UniProt ID
- O60667
- Long Name
- Fc Fragment Of IgM Receptor
- Cellular Localization
- Cell membrane; Early endosome membrane; Golgi apparatus, trans-Golgi network membrane; Lysosome membrane
- Post Translation Modifications
- Phosphorylated on both Tyr and Ser residues.
O-glycosylated.
Sialylated.
O-linked glycans regulate trafficking to the plasma membrane.
Modification sites at PhosphoSitePlus
Modification sites at neXtProt
Glycosylation from GlyGen 2 sites, 2 O-linked glycans (2 sites)
- Protein Refseq
- XP_047290287.1; XP_047290290.1; XP_054195589.1; XP_054195590.1; NP_001135945.1
- Function
- FCMR (Fc mu receptor) is a receptor that binds to IgM antibodies, playing a role in immune complex clearance and B cell signaling. It influences immune responses and is implicated in autoimmune diseases.
Recommended Products
Secondary Antibody
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "FCMR"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-153CQ | Anti-Human FCMR Recombinant Antibody (A38) | WB, IP | |
TAB-154CQ | Anti-Human FCMR Recombinant Antibody (6E9) | ELISA, FC, WB | |
TAB-153CQ-S(P) | Anti-Human FCMR Recombinant Antibody scFv Fragment (A38) | WB, IP | |
TAB-154CQ-S(P) | Anti-Human FCMR Recombinant Antibody scFv Fragment (6E9) | ELISA, FC, WB | |
TAB-153CQ-F(E) | Anti-Human FCMR Recombinant Antibody Fab Fragment (A38) | WB, IP |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0325-FY120. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, Cyt, Stim, PP, Agonist
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: WB, IF, FuncS
Application: IHC, ELISA, FC, WB, ADCC, FuncS
Application: WB, ELISA, FC, IHC, IP
Application: ELISA, Inhib, FuncS
Application: ELISA, FC, Inhib
Application: ELISA, Vaccine, FuncS
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.